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Abstract
Mullerian adenosarcoma (MA) of ovary with sarcomatous
(rhabdomyoblastic) overgrowth is an extremely rare
malignant type of female genital tract neoplasm. These
tumours are highly aggressive and presence of
heterologous elements is associated with worse
prognosis. A 44 year old female presented with lower
abdominal pain and distension. She had history of
removal of tumour from pouch of Douglas in 2006 for
which she did not receive any additional treatment nor
did she keep continuous follow up. Current preoperative
radiological examination revealed bilateral ovarian
masses. She underwent abdominal hysterectomy with
bilateral oophorectomy. Microscopic examination
revealed biphasic tumours exhibiting sarcomatous
overgrowth with rhabdomyoblastic differentiation.
Review of the previous biopsy revealed low grade
Mullerian adenosarcoma without sarcomatous
overgrowth. Hence the current tumour was considered
recurrent. This report highlights the aggressive nature of
MA even with low grade morphological features and
emphasizes the importance of continuous follow up and
additional treatment.
Keywords: Mullerian adenosarcoma, sarcomatous
overgrowth, rhabomyoblastic differentiation, extrauterine.
Introduction
Malignant mesenchymal neoplasms account for 1-3% of
all female genital tract tumours and Mullerian
Adenosarcoma (MA) constitute 8-10% of these
malignancies.1-3 MAs commonly arise in the uterus and
presents as a polypoid mass. However, they can also
involve extrauterine sites and ovary is the most common
among these sites. Other extrauterine sites include pelvis,
vagina, fallopian tube, peritoneum, intestine, liver, etc.1-3
According to the classical description of Clement and
Scully, MA is a mixed neoplasm comprising of malignant
stromal and benign epithelial component.1,4,5 MA with
sarcomatous overgrowth is defined as partial overgrowth
of an otherwise typical adenosarcoma by pure high grade
sarcoma occupying at least 25% of the tumour mass.
Further classification of MA depends upon differentiation
of mesenchymal elements; Homologous tumours are
composed of nonspecific spindle shaped sarcomatous
cells, whereas heterologous tumours are associated with
myoid, chondroid and osteoid differentiation.2,3 Tumours
with sarcomatous overgrowth have aggressive clinical
course as compared to tumours without sarcomatous
growth.2
Case Presentation
An abdominal hysterectomy and bilateral oophorectomy
specimen was received at Histopathology Section,
Department of Pathology and Laboratory Medicine, Aga
Khan University Hospital, Karachi in April 2017. Patient was
a 44 year old female who presented to the gynaecologist
with complaint of lower abdominal pain. On clinical
examination, a tender mass was palpable in the lower
abdomen. Her preoperative ultrasound revealed a
complex mass in right adnexa. MRI scan of pelvis showed
bilateral ovarian masses. Right ovarian mass measured 8.5
x 8 cm with solid enhancing and cystic necrotic
components. Left ovarian solid mass measured 5 x 4.5 cm.
Uterus was bulky and contained multiple well defined
hypo intense masses (Fibroids). There was no evidence of
pelvic visceral, omental and peritoneal involvement. Pelvic
lymphadenopathy was also not seen. Her serum CA-125
level was 50.9 u/ml. She underwent total abdominal
hysterectomy with bilateral oophorectomy.
Gross examinations showed the uterus, cervix, fallopian
tubes and multiple separate light brown, soft to firm,
irregular pieces of tumour tissue. The largest of these
tissue pieces measured 13 x 7 cm and the rest measured
11 x 9 cm in aggregate. On sectioning, cut surface was tan
to light brown and exhibited areas of haemorrhage,
necrosis and multiple cystic spaces. Uterus, cervix and
fallopian tubes were grossly not involved by tumour.
Myometrium also showed three fibroids.
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Microscopic examination of
tumour tissue pieces revealed an
extensively necrotic tumour. The
viable areas showed a biphasic
growth pattern comprising of
predominant stromal component
and scattered irregular, ectatic and
compressed glands lined by bland
looking columnar cells showing
nuclear stratification. The stroma
component showed marked
hypercellularity with areas of
necrosis and myxoid change. At
some areas stromal cells appeared
condensed around the glands
(Figure 1A-D). Stromal cells were
spindle to stellate in shape and
exhibited prominent
rhabdomyoblastic differentiation.
Immunohistochemical (IHC) stains
Desmin and myogenin also
confirmed the rhabdomyoblastic
nature of stromal cells (Figure 2A-
D). The nuclei were highly
pleomorphic and hyperchromatic.
Frequent mitotic figures
(approximately 22/10 HPF) were
also appreciated. At foci, the
background stroma showed
hyalinized plaques resembling
"collagen rossettes". Endometriosis
and ovarian sex cord like elements
were not found. Focally, normal
ovarian stroma was also identified.
Hence, the case was diagnosed as
"Mullerian adenosarcoma with
r h a b d o m y o s a r c o m a t o u s
overgrowth".
Later the patient also revealed that
she had undergone laparotomy
and excision of a tumour in the
pouch of Douglas in 2006. There
was no evidence of disease in the
ovaries, other pelvic organs and
omentum at that time. The slides
of the previous biopsy were
reviewed which also revealed low
grade adenosarcoma without any
other lineage differentiation.
Hence, we consider our case to be
recurrence of the initial tumour.
Since the patient belonged to a
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Figure-1: (A) Low power view of biphasic tumour exhibiting cystic spaces. Normal ovarian tissue is also appreciable
on left side. (B) Medium power view showing condensation of stromal component around dilated glandular
structures. (C) Medium power view showing compression of epithelial component by adjacent stromal component.
(D) High power view showing benign low columnar epithelial lining surrounded by low grade sarcomatous
component.
Figure-2: (A) Medium power view and (B) High power view of areas showing rhadomyosarcomatous overgrowth. (C)
Desmin and (D) Myogenin IHC stains demonstrating positive expression and confirming rhabdomyoblastic differentiation of
tumour cells.
remote rural area of the country, she neither kept
continuous follow up nor received additional treatment
at that time.
Patient was disease free 4 months after the removal of
the recurrent tumour. Since the tumour had acquired
high grade and sarcomatous overgrowth, patient was
offered adjuvant radiotherapy which she refused due
to financial reasons. She was then advised to keep
close follow up with her gynaecologist and
oncologist.
Discussion
The term "Mullerian adenosarcoma" was used first in 1974
by Clement and Scully for a distinctive uterine tumour
characterized by a malignant, usually low grade, stromal
component, and a generally benign, but occasionally
atypical, glandular epithelial component.5 Since that time,
similar cases have been reported from various places in
the literature, most of which include a small number of
patients.1-3,6-8 The largest series on MA included only 40
patients.2
MA can occur at any age including adolescence.
Extrauterine MAs occur at younger age than their uterine
counterparts as seen in our patient. Median age for
uterine tumours is 71 years as compared to 53 years for
extrauterine tumours. In vast majority (97.5%) of cases
may tend to occur unilaterally.2 In contrast, the ovaries
were bilaterally involved in our case. The common
presenting manifestations include abdominal pain,
abdominal distention with palpable mass and irregular
vaginal bleeding as also observed in our case.3 Some of
these extrauterine tumours have been associated with
and presumably arise from endometriosis. While others
are not associated with endometriosis, they are thought
to arise from surface epithelium, ovarian stroma, or
peritoneal mesothelium as part of secondary Mullerian
system.6,7
Mullerian adenosarcoma of ovary is generally similar
microscopically to uterine adenosarcoma except a few
differences like sarcomatous overgrowth is seen in 30% of
ovarian cases as compared to 8% in uterine
adenosarcoma and SCLE (Sex cord like elements) were
seen in 15% of ovarian cases as compared to 7% in their
uterine counterparts.2,4
Almost all endometrioid tumours of the ovary are
carcinomas except for rare tumour types i.e.
adenofibroma and MA. Adenofibroma resembles MA
except that the stroma of adenofibroma lacks nuclear
pleomorphism and mitotic activity found in
adenosarcoma. The differential diagnosis in any
individual case depends on the morphologic features
such as presence or absence of heterologous
elements, sex cord like elements, and sarcomatous
overgrowth. The differential diagnosis of MA with
sarcomatous overgrowth also includes endometrial
stromal sarcoma [ESS], immature teratoma, malignant
mullerian mixed tumours (MMMT) and pure sarcomas
when heterologous elements are present.  ESS occurs
in same age group as mullerian adenosarcoma and is
usually unilateral. ESS resembles stromal component
of adenosarcoma but lacks its glandular component.
Thorough sampling should be done to search for
epithelial component of MA as the prognosis of MA is
worse than ESS. Immature teratoma can be excluded
on the basis of age as these tumours most commonly
occur in the first three decades of life and are almost
nonexistent after menopause, and contain embryonal
neuroectodermal elements and endodermal derivates
in almost all cases. In contrast to MA, malignant
mullerian mixed tumours (MMMT) typically have a
high grade mesenchymal component and an invasive
carcinomatous component. The presence of typical
adenosarcoma areas rule out the possibilities of pure
sarcomas.1,2,7 Ovarian MAs have poor prognosis,
higher recurrence and higher mortality rates than their
more common uterine counterparts. Five year disease
free survival is less than 25%.8,9 The main reason is
probably related to the location of tumours with
respect to the abdominal cavity and the lack of an
anatomic barrier to spread. Another reason may also
be the result of the larger size, higher stage, and
higher frequency of rupture of the ovarian tumours.
Surgery is the mainstay of treatment and additional
chemotherapy and/or radiotherapy is administered in
a proportion of patients.2
Conclusion
MAs of ovary are rare aggressive tumours which can
present with recurrence after many years, even with low
grade morphological features. Additional aggressive
treatment modalities and close clinical follow up should
be considered in all cases.
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